Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Sasner

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Biorxiv : the Preprint Server for Biology|November 24, 2025
WSB.<i>APP/PS1</i> mice develop age-dependent cerebral amyloid angiopathy, cerebrovascular deficits, and white matter damage, which are modified by humanized <i>APOE</i> allelesKristen D Onos, Olivia J Marola, Asli Uyar, et al.
Frontiers in Aging Neuroscience|October 28, 2021
Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEε4 and Trem2*R47HKevin P Kotredes, Adrian Oblak, Ravi S Pandey, et al.
Frontiers in Aging Neuroscience|February 24, 2022
Corrigendum: Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEε4 and Trem2<sup>*</sup>R47HKevin P Kotredes, Adrian Oblak, Ravi S Pandey, et al.
Frontiers in Aging Neuroscience|July 11, 2022
<i>Plcg2</i> Interacts With High Fat/High Sugar Diet to Accelerate Alzheimer's Disease-Relevant Phenotypes in MiceAdrian L Oblak, Kevin P Kotredes, Ravi S Pandey, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 26, 2022
Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL-AD preclinical testing core studyKristen D Onos, Sara K Quinney, David R Jones, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 12, 2024
Characterizing molecular and synaptic signatures in mouse models of late-onset Alzheimer's disease independent of amyloid and tau pathologyKevin P Kotredes, Ravi S Pandey, Scott Persohn, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Characterizing Molecular and Synaptic Signatures in mouse models of Late-Onset Alzheimer's Disease Independent of Amyloid and Tau PathologyKevin P Kotredes, Ravi S Pandey, Scott Persohn, et al.
Nature|January 21, 2026
Ageing promotes microglial accumulation of slow-degrading synaptic proteinsIan H Guldner, Viktoria P Wagner, Patricia Moran-Losada, et al.
Frontiers in Aging Neuroscience|August 9, 2021
Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD StudyAdrian L Oblak, Peter B Lin, Kevin P Kotredes, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 18, 2022
Prophylactic evaluation of verubecestat on disease- and symptom-modifying effects in 5XFAD miceAdrian L Oblak, Zackary A Cope, Sara K Quinney, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Biorxiv : the Preprint Server for Biology|November 24, 2025
WSB.<i>APP/PS1</i> mice develop age-dependent cerebral amyloid angiopathy, cerebrovascular deficits, and white matter damage, which are modified by humanized <i>APOE</i> allelesKristen D Onos, Olivia J Marola, Asli Uyar, et al.
Frontiers in Aging Neuroscience|October 28, 2021
Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEε4 and Trem2*R47HKevin P Kotredes, Adrian Oblak, Ravi S Pandey, et al.
Frontiers in Aging Neuroscience|February 24, 2022
Corrigendum: Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEε4 and Trem2<sup>*</sup>R47HKevin P Kotredes, Adrian Oblak, Ravi S Pandey, et al.
Frontiers in Aging Neuroscience|July 11, 2022
<i>Plcg2</i> Interacts With High Fat/High Sugar Diet to Accelerate Alzheimer's Disease-Relevant Phenotypes in MiceAdrian L Oblak, Kevin P Kotredes, Ravi S Pandey, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 26, 2022
Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL-AD preclinical testing core studyKristen D Onos, Sara K Quinney, David R Jones, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 12, 2024
Characterizing molecular and synaptic signatures in mouse models of late-onset Alzheimer's disease independent of amyloid and tau pathologyKevin P Kotredes, Ravi S Pandey, Scott Persohn, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Characterizing Molecular and Synaptic Signatures in mouse models of Late-Onset Alzheimer's Disease Independent of Amyloid and Tau PathologyKevin P Kotredes, Ravi S Pandey, Scott Persohn, et al.
Nature|January 21, 2026
Ageing promotes microglial accumulation of slow-degrading synaptic proteinsIan H Guldner, Viktoria P Wagner, Patricia Moran-Losada, et al.
Frontiers in Aging Neuroscience|August 9, 2021
Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD StudyAdrian L Oblak, Peter B Lin, Kevin P Kotredes, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 18, 2022
Prophylactic evaluation of verubecestat on disease- and symptom-modifying effects in 5XFAD miceAdrian L Oblak, Zackary A Cope, Sara K Quinney, et al.
Pageof 6